ASAHI INTECC CO., LTD. Is the world leader in the production of coronary conductors and devices for overcoming chronic occlusions. The company was founded in 1972, under the name of Asahi Mini Rope Co., Ltd. in Japan, as a manufacturer of ultra-thin steel wire braiding and conductor materials. Since 1988 the company is called ASAHI INTECC CO., LTD.
At this moment, ASAHI INTECC CO., LTD. has production sites in Japan, Thailand, Vietnam, as well as a distribution network around the world. Not stopping at the achieved, the company ASAHI INTECC CO., LTD. does not stop the development of new high-quality products and, at the moment, produces: coronary conductors, peripheral conductors, microconductors, microcatheters, guiding catheters and other products.
Super selective microcatheter to achieve distally located targets.
The company Eucatech AG (Rheinfelden, Germany) was founded in 1997, today has an extensive distribution network in more than 30 countries. Mostly Eucatech AG specializes in vascular interventional cardiology and radiology. Among the main products of this company you will find balloon catheters, stents, stenting systems, multi-purpose catheters, drug-coated stents, stenting systems with medicated coating, as well as a unique Comouflage® coating process
Goodman Co., Ltd. - a private Japanese company, established in 1975. Started its activities as an importer and distributor (since 1981) of medical equipment and medical products. However, in 1984 she organized her own production of medical devices for minimally invasive intravascular operations. Goodman Co., Ltd. includes or entered such well-known enterprises as Cosmo Co. Ltd., LightLab Imaging Inc. (later it was sold to St. Jude Medical), Intella Interventional Systems Inc., Avantec Vascular Corp. Currently Goodman Co., Ltd. has production sites in Japan, the United States and Ireland. Goodman Co., Ltd. This is an uncompromising Japanese quality and perfection of technical solutions. All products of the company are authorized for use in Japan and Western Europe. All products of Goodman Co., Ltd. registered and authorized for use in Belarus and Russia.
Assomedica Ltd Co is the exclusive distributor of Goodman Co., Ltd. in Russia, Belarus and Kazakhstan.
Acist Medical System is the world leader in the production of contrast systems for angiography. It was the company Acist Medical Systems that introduced the concept of "variable flow" into the process of X-ray endovascular interventions, which allowed replacing the manual introduction of contrast in coronary angiography, using an automatic injector. This made coronary angiography much safer and more effective, allowed to reduce the dose of contrast administered and, as a consequence, reduced the likelihood of development of contrast-induced nephropathy.
The company Acist Medical Systems was founded in 1991 and now more than 10 million procedures are performed worldwide with the help of Acist CVi inverters.
Straub Medical AG is the world leader in the manufacture of systems for mechanical intravascular thrombectomy.
The idea of mechanical intravascular thrombectomy was born in the early 90s. In 1995, a patent of the Rotarex system was obtained. In 1999, the system received CE Mark for the Rotarex system. In 2004-2005, the Aspirex system was patented and received the CE Mark system.
Currently, the company produces and exports products to more than 50 countries. Straub Medical AG does not stop the development of new products and the improvement of existing models, the emphasis is on improving efficiency, safety, as well as reducing the time of the operation.
The company Stentys S.A. was founded in 2006 for the development and production of coronary stents with the property of adaptive apposition - Self-Aporing ® Stent System
These stents are able to change the diameter after installation without the need for balloon post-dilatation, which facilitates the correct choice of the stent size for myocardial infarction and for certain anatomical characteristics of the affected area - the left coronary artery trunk, bifurcations, ectatic artery transformation, and other recalibration options.
The program of clinical trials, in which more than 2,500 patients participated, demonstrated excellent angiographic and long-term results of stenting, as well as high safety of stents with adaptive apposition by Stentys S.A.
Stents with adaptive apposition simplify the choice of stent size for myocardial infarction
Founded in 1987 in the United States and rightfully considered a world leader, Merit Medical Systems Inc. produces various devices that are used in diagnostic and intervention interventions on coronary and peripheral vessels, as well as in other non-vascular diseases